Physician profile

Evan S Sorett

Pulmonary Disease · Great Neck, NY

NPI 1386683506

$17,954.42

in general payments reported to CMS, 2019-2025

47 companies · $2,291 in 2025

The $2,291 reported for 2025 was more than what 78% of Pulmonary Disease providers received nationally (typical 2025 total: $500).

See the full distribution for Pulmonary Disease

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$7,835.71
Education$240.92

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Glaxosmithkline, LLC. $3,337.42 2019-2025 Nucala, Trelegy Ellipta, Arexvy
Astrazeneca Pharmaceuticals LP $2,085.17 2019-2025 Tezspire, Fasenra, Airsupra
Boehringer Ingelheim Pharmaceuticals, INC. $1,981.25 2019-2025 Ofev, Stiolto Respimat, Spiriva Respimat
Regeneron Healthcare Solutions, INC. $908.69 2020-2025 Dupixent
Abbott Laboratories $795.72 2020-2025 Thoratec Heartmate 3 Lvas Implant Kit
Ekos Corporation $720.27 2019
Genzyme Corporation $597.09 2019-2025
Novartis Pharmaceuticals Corporation $595.70 2019-2024
Philips North America LLC $595.20 2019-2025 Vest Therapy Und, (Ak6) Vest Therapy
Mylan Specialty L.P. $588.70 2019-2024 Yupelri
Actelion Pharmaceuticals US, INC. $519.24 2020-2025 Opsumit, Uptravi
Genentech USA, INC. $440.70 2019-2025 Xolair
Baxter Healthcare $432.32 2022-2024 Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System
Sunovion Pharmaceuticals INC. $427.90 2019-2020
Insmed, INC. $316.12 2019-2025 Arikayce
Show all 47 companies
CompanyGeneral paymentsYearsTop products
Grifols USA, LLC $312.62 2019-2025 Prolastin-C Liquid
Abiomed $297.82 2024-2025 Impella
Advanced Respiratory, INC $225.71 2019-2021
Janssen Pharmaceuticals, INC $224.51 2020-2022
Mallinckrodt Hospital Products INC. $221.24 2020-2025 Acthar
United Therapeutics Corporation $185.66 2021-2025 Tyvaso, Tyvaso
Amgen INC. $176.62 2021-2023 Tezspire, Tavneos
Viatris Specialty LLC $174.94 2025 Yupelri
Electromed, INC. $158.01 2019-2023 Smartvest
Teva Pharmaceuticals USA, INC. $153.95 2019-2023
Merck Sharp & Dohme LLC $147.50 2019-2025 Capvaxive, Winrevair
Olympus America INC. $144.45 2024 Spin Vision Video Processor
Pulmonx Corporation $125.00 2019
Chiesi USA, INC. $106.65 2019-2024 Cleviprex
Vifor Pharma, INC. $106.55 2024-2025 Zemaira
Shionogi INC $104.18 2022-2024 Fetroja
Sanofi-Aventis U.S. LLC $98.99 2023
Inogen, INC. $90.27 2022-2023 Inogen One G5 Oxygen Concentrator - Bluetooth
Circassia INC. $71.78 2019
Inspire Medical Systems, INC. $62.90 2025 Inspire
Gilead Sciences, INC. $54.98 2019-2021
Verona Pharma, INC. $48.50 2025 Ohtuvayre
Takeda Pharmaceuticals U.S.A., INC. $46.87 2020-2024 Glassia
Shire North American Group INC $46.87 2019
La Jolla Pharmaceutical Company $45.58 2019
Abbvie INC. $40.35 2022-2024
Alexion Pharmaceuticals, INC. $31.95 2023 Ultomiris
Ani Pharmaceuticals, INC. $26.35 2024 Purified Cortrophin Gel
E.R. Squibb & Sons, L.L.C. $23.96 2020-2021
Inari Medical, INC. $20.49 2020
Pfizer INC. $18.97 2021
Paratek Pharmaceuticals, INC. $18.71 2024 Nuzyra

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Evan S Sorett

$17,954.42

in general payments reported 2019-2025

Years
2019-2025
Top company
Glaxosmithkline, LLC.
Context
The $2,291 reported for 2025 was more than what 78% of Pulmonary Disease providers received nationally (typical 2025 total: $500).

https://glasscript.com/doctor/107577/evan-s-sorett

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.